Trial intelligence / Profile preview

Real-world neoadjuvant pyrotinib in HER2-positive breast cancer

ChiCTR2200056532Phase 4Not yet recruiting

Sponsor

Henan Provincial People's Hospital

Start

Mar 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1